의약품 관련 법령
BfArM/PEI Announcement of 13-Jul-2018 on the Obligation to Notify a New Importation Country in Parallel Imported Medicinal Products According to § 29 of the German Drug Law (AMG)
| 작성자 | 관리자 | ||
|---|---|---|---|
| 작성일 | 2018-07-13 | 조회수 | 657 |
| 국가정보 | 유럽>독일 | ||
| 출처 | BUNDESANZEIGER | ||
| 원문 | www.bundesanzeiger.de | ||
| 첨부파일 | |||
BfArM-PEI Announcement of 13-Jul-2018 on the Obligation to Notify a New Importation Country in Parallel Imported Medicinal Products According to § 29 of the German Drug Law (AMG).pdf(189.62KB)
BfArM/PEI Announcement of 13-Jul-2018 on the Obligation to Notify a New Importation Country in Parallel Imported Medicinal Products According to § 29 of the German Drug Law (AMG)
- 이전글 Evaluation Report: Drug Approval Document of BRINEURA (Cerliponase alfa)
- 다음글 BfArM FAQs: On National Variation Notifications, Purely National Variation Procedures
